| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.933 | 0.003 | 0.933 | Aldehyde oxidase inhibitor | 0.233 0.089 CID_20717005 | ||
| 0.87 | 0.002 | 0.87 | Alcohol oxidase inhibitor | 0.159 0.009 CID_20717005 | ||
| 0.846 | 0.002 | 0.882 | Alpha-N-acetylglucosaminidase inhibitor | 0.882 0.001 CID_20717005 | CID_20717005 | |
| 0.776 | 0.004 | 0.776 | 5 Hydroxytryptamine release stimulant | 0.584 0.016 CID_20717005 | ||
| 0.641 | 0.007 | 0.641 | 5 Hydroxytryptamine release inhibitor | 0.591 0.012 CID_20717005 | ||
| 0.63 | 0.004 | 0.63 | Peroxidase inhibitor | |||
| 0.612 | 0.017 | 0.746 | Cholesterol antagonist | 0.746 0.005 CID_20717005 | CID_20717005 | |
| 0.603 | 0.036 | 0.707 | Caspase 9 stimulant | 0.707 0.023 CID_20717005 | CID_20717005 | |
| 0.575 | 0.013 | 0.73 | Histamine release inhibitor | 0.73 0.004 CID_20717005 | CID_20717005 | |
| 0.555 | 0.02 | 0.59 | Vasodilator, peripheral | 0.59 0.017 CID_20717005 | CID_20717005 | |
| 0.527 | 0.019 | 0.527 | GABA C receptor rho-3 antagonist | |||
| 0.468 | 0.003 | 0.584 | Triose-phosphate isomerase inhibitor | 0.584 0.002 CID_20717005 | CID_20717005 | |
| 0.47 | 0.016 | 0.47 | Superoxide dismutase inhibitor | |||
| 0.487 | 0.04 | 0.487 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.468 | 0.023 | 0.468 | Interleukin antagonist | |||
| 0.448 | 0.004 | 0.448 | GABA C receptor agonist | 0.128 0.044 CID_20717005 | ||
| 0.447 | 0.003 | 0.466 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.466 0.003 CID_20717005 | CID_20717005 | |
| 0.433 | 0.004 | 0.523 | UDP-glucose 4-epimerase inhibitor | 0.523 0.002 CID_20717005 | CID_20717005 | |
| 0.424 | 0.003 | 0.424 | Ferrochelatase inhibitor | 0.097 0.074 CID_20717005 | ||
| 0.425 | 0.005 | 0.425 | Insulin secretagoues | 0.421 0.005 CID_20717005 | ||
| 0.418 | 0.003 | 0.418 | Phenylalanine 4-hydroxylase inhibitor | 0.078 0.039 CID_20717005 | ||
| 0.466 | 0.051 | 0.671 | Antibacterial | 0.671 0.011 CID_20717005 | CID_20717005 | |
| 0.419 | 0.011 | 0.419 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.424 | 0.016 | 0.572 | Interleukin agonist | 0.572 0.005 CID_20717005 | CID_20717005 | |
| 0.408 | 0.004 | 0.601 | NADH dehydrogenase inhibitor | 0.601 0.002 CID_20717005 | CID_20717005 | |
| 0.426 | 0.024 | 0.789 | Hypoglycemic | 0.789 0.004 CID_20717005 | CID_20717005 | |
| 0.417 | 0.014 | 0.458 | Anesthetic general | 0.458 0.011 CID_20717005 | CID_20717005 | |
| 0.427 | 0.028 | 0.638 | Vasodilator, coronary | 0.638 0.006 CID_20717005 | CID_20717005 | |
| 0.419 | 0.022 | 0.466 | Hypolipemic | 0.466 0.015 CID_20717005 | CID_20717005 | |
| 0.415 | 0.019 | 0.415 | Calcium channel activator | 0.234 0.167 CID_20717005 | ||
| 0.4 | 0.004 | 0.4 | Succinate dehydrogenase inhibitor | 0.194 0.054 CID_20717005 | ||
| 0.407 | 0.017 | 0.407 | RNA-directed DNA polymerase inhibitor | 0.346 0.024 CID_20717005 | ||
| 0.395 | 0.022 | 0.561 | DNA synthesis inhibitor | 0.561 0.009 CID_20717005 | CID_20717005 | |
| 0.381 | 0.01 | 0.381 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.372 | 0.004 | 0.372 | Adenylate kinase inhibitor | 0.279 0.008 CID_20717005 | ||
| 0.377 | 0.011 | 0.701 | Amylase inhibitor | 0.701 0.003 CID_20717005 | CID_20717005 | |
| 0.369 | 0.004 | 0.369 | Nitric-oxide synthase stimulant | 0.316 0.008 CID_20717005 | ||
| 0.378 | 0.025 | 0.378 | Sodium/bile acid cotransporter inhibitor | 0.214 0.169 CID_20717005 | ||
| 0.356 | 0.005 | 0.356 | Glutamate dehydrogenase inhibitor | 0.181 0.012 CID_20717005 | ||
| 0.35 | 0.004 | 0.35 | Carbamoyl phosphate synthetase inhibitor | 0.151 0.011 CID_20717005 | ||
| 0.374 | 0.036 | 0.579 | Interleukin 2 agonist | 0.579 0.004 CID_20717005 | CID_20717005 | |
| 0.4 | 0.063 | 0.633 | Immunosuppressant | 0.633 0.009 CID_20717005 | CID_20717005 | |
| 0.387 | 0.053 | 0.755 | Antithrombotic | 0.755 0.005 CID_20717005 | CID_20717005 | |
| 0.343 | 0.013 | 0.471 | Peptidyltransferase inhibitor | 0.471 0.004 CID_20717005 | CID_20717005 | |
| 0.326 | 0.004 | 0.326 | GABA C receptor antagonist | |||
| 0.327 | 0.005 | 0.327 | Histidine decarboxylase inhibitor | |||
| 0.329 | 0.009 | 0.329 | Aldehyde dehydrogenase inhibitor | 0.302 0.011 CID_20717005 | ||
| 0.34 | 0.028 | 0.435 | Cyclic AMP phosphodiesterase inhibitor | 0.435 0.012 CID_20717005 | CID_20717005 | |
| 0.315 | 0.005 | 0.436 | Phosphofructokinase-1 inhibitor | 0.436 0.003 CID_20717005 | CID_20717005 | |
| 0.367 | 0.059 | 0.629 | Immunostimulant | 0.629 0.014 CID_20717005 | CID_20717005 | |
| 0.307 | 0.003 | 0.307 | Biliverdin reductase inhibitor | 0.177 0.007 CID_20717005 | ||
| 0.306 | 0.005 | 0.306 | Porphobilinogen synthase inhibitor | |||
| 0.32 | 0.021 | 0.32 | Gastrin inhibitor | 0.255 0.073 CID_20717005 | ||
| 0.304 | 0.006 | 0.304 | Catalase inhibitor | 0.072 0.053 CID_20717005 | ||
| 0.316 | 0.019 | 0.316 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.267 0.035 CID_20717005 | ||
| 0.296 | 0.003 | 0.296 | Fumarate hydratase inhibitor | 0.095 0.006 CID_20717005 | ||
| 0.327 | 0.04 | 0.552 | Vasodilator | 0.552 0.008 CID_20717005 | CID_20717005 | |
| 0.292 | 0.009 | 0.292 | Nav1.1 sodium channel blocker | |||
| 0.296 | 0.019 | 0.296 | Phospholipase C inhibitor | 0.215 0.035 CID_20717005 | ||
| 0.293 | 0.021 | 0.433 | Interferon gamma antagonist | 0.433 0.009 CID_20717005 | CID_20717005 | |
| 0.288 | 0.019 | 0.288 | Insulin sensitizer | 0.223 0.052 CID_20717005 | ||
| 0.289 | 0.021 | 0.297 | Neurotrophic factor enhancer | 0.297 0.019 CID_20717005 | CID_20717005 | |
| 0.269 | 0.004 | 0.269 | GABA C receptor rho-1 antagonist | |||
| 0.268 | 0.005 | 0.268 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.245 0.005 CID_20717005 | ||
| 0.367 | 0.105 | 0.367 | Calcium channel L-type activator | |||
| 0.37 | 0.109 | 0.882 | Cyclophilin D inhibitor | 0.882 0.005 CID_20717005 | CID_20717005 | |
| 0.265 | 0.004 | 0.265 | Glutamate decarboxylase inhibitor | 0.076 0.048 CID_20717005 | ||
| 0.293 | 0.034 | 0.293 | Growth hormone agonist | |||
| 0.265 | 0.009 | 0.271 | Mannose-6-phosphate isomerase inhibitor | 0.271 0.008 CID_20717005 | CID_20717005 | |
| 0.308 | 0.054 | 0.308 | Insulysin inhibitor | |||
| 0.318 | 0.063 | 0.418 | Spasmolytic | 0.418 0.037 CID_20717005 | CID_20717005 | |
| 0.283 | 0.032 | 0.283 | P-glycoprotein inhibitor | 0.175 0.084 CID_20717005 | ||
| 0.258 | 0.012 | 0.482 | Expectorant | 0.482 0.004 CID_20717005 | CID_20717005 | |
| 0.249 | 0.003 | 0.249 | Acyl-CoA dehydrogenase inhibitor | 0.155 0.009 CID_20717005 | ||
| 0.261 | 0.016 | 0.261 | Cholesterol synthesis inhibitor | 0.174 0.034 CID_20717005 | ||
| 0.246 | 0.003 | 0.246 | Aconitate hydratase inhibitor | 0.056 0.03 CID_20717005 | ||
| 0.252 | 0.013 | 0.358 | ATPase inhibitor | 0.358 0.004 CID_20717005 | CID_20717005 | |
| 0.275 | 0.037 | 0.721 | Hepatoprotectant | 0.721 0.004 CID_20717005 | CID_20717005 | |
| 0.24 | 0.006 | 0.24 | Creatine kinase inhibitor | 0.091 0.07 CID_20717005 | ||
| 0.281 | 0.048 | 0.285 | Psychostimulant | 0.285 0.047 CID_20717005 | CID_20717005 | |
| 0.237 | 0.005 | 0.237 | Electrolyte absorption antagonist | |||
| 0.289 | 0.059 | 0.289 | Transcription factor STAT3 inhibitor | 0.202 0.132 CID_20717005 | ||
| 0.268 | 0.04 | 0.268 | Neuropeptide Y2 antagonist | |||
| 0.234 | 0.01 | 0.234 | Arachidonic acid antagonist | 0.206 0.028 CID_20717005 | ||
| 0.226 | 0.004 | 0.242 | Neuraminidase (influenza) inhibitor | 0.242 0.004 CID_20717005 | CID_20717005 | |
| 0.236 | 0.015 | 0.236 | Aminopeptidase B inhibitor | |||
| 0.284 | 0.063 | 0.284 | Cardiotonic | |||
| 0.226 | 0.006 | 0.226 | Adenylate cyclase stimulant | 0.176 0.03 CID_20717005 | ||
| 0.238 | 0.018 | 0.407 | Cell wall synthesis inhibitor | 0.407 0.006 CID_20717005 | CID_20717005 | |
| 0.228 | 0.009 | 0.228 | Mucolytic | 0.207 0.012 CID_20717005 | ||
| 0.236 | 0.02 | 0.355 | Hexokinase inhibitor | 0.355 0.006 CID_20717005 | CID_20717005 | |
| 0.216 | 0.004 | 0.216 | Neuraminidase inhibitor | 0.215 0.004 CID_20717005 | ||
| 0.229 | 0.017 | 0.229 | GABA C receptor rho-2 antagonist | |||
| 0.28 | 0.068 | 0.28 | Transcription factor STAT inhibitor | |||
| 0.216 | 0.004 | 0.241 | Glutamate release inhibitor | 0.241 0.004 CID_20717005 | CID_20717005 | |
| 0.226 | 0.015 | 0.252 | Microtubule formation inhibitor | 0.252 0.008 CID_20717005 | CID_20717005 | |
| 0.224 | 0.015 | 0.224 | Toll-Like receptor 2 antagonist | 0.128 0.069 CID_20717005 | ||
| 0.213 | 0.006 | 0.213 | Aminopeptidase I inhibitor | 0.073 0.049 CID_20717005 | ||
| 0.215 | 0.009 | 0.215 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.236 | 0.031 | 0.333 | Melanin inhibitor | 0.333 0.018 CID_20717005 | CID_20717005 | |
| 0.294 | 0.089 | 0.674 | Apoptosis antagonist | 0.674 0.005 CID_20717005 | CID_20717005 | |
| 0.22 | 0.015 | 0.22 | Aurora-C kinase inhibitor | |||
| 0.238 | 0.033 | 0.238 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.222 | 0.018 | 0.222 | Cathepsin H inhibitor | |||
| 0.234 | 0.031 | 0.281 | Protein kinase stimulant | 0.281 0.02 CID_20717005 | CID_20717005 | |
| 0.209 | 0.006 | 0.209 | Prostaglandin EP2 antagonist | 0.07 0.033 CID_20717005 | ||
| 0.224 | 0.022 | 0.224 | Adenylate cyclase inhibitor | 0.188 0.028 CID_20717005 | ||
| 0.205 | 0.007 | 0.205 | Argininosuccinate synthase inhibitor | 0.138 0.013 CID_20717005 | ||
| 0.215 | 0.021 | 0.215 | Cystathionine beta-synthase inhibitor | 0.16 0.037 CID_20717005 | ||
| 0.248 | 0.055 | 0.248 | MAP kinase kinase 2 inhibitor | |||
| 0.197 | 0.004 | 0.197 | Ca2+-transporting ATPase inhibitor | 0.197 0.004 CID_20717005 | ||
| 0.206 | 0.019 | 0.235 | CF transmembrane conductance regulator agonist | 0.235 0.009 CID_20717005 | CID_20717005 | |
| 0.214 | 0.029 | 0.214 | Anesthetic local | |||
| 0.187 | 0.003 | 0.326 | Alpha-mannosidase inhibitor | 0.326 0.002 CID_20717005 | CID_20717005 | |
| 0.206 | 0.023 | 0.206 | Antiadrenergic | |||
| 0.223 | 0.041 | 0.223 | Histone acetyltransferase inhibitor | |||
| 0.203 | 0.023 | 0.203 | Adrenaline antagonist | |||
| 0.195 | 0.015 | 0.195 | Protease inhibitor | |||
| 0.19 | 0.012 | 0.19 | Sphingomyelinase inhibitor | 0.171 0.017 CID_20717005 | ||
| 0.216 | 0.04 | 0.216 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.281 | 0.106 | 0.672 | Transcription factor NF kappa B inhibitor | 0.672 0.024 CID_20717005 | CID_20717005 | |
| 0.183 | 0.008 | 0.183 | Ornithine carbamoyltransferase inhibitor | 0.087 0.019 CID_20717005 | ||
| 0.194 | 0.021 | 0.387 | Cyclooxygenase 3 inhibitor | 0.387 0.004 CID_20717005 | CID_20717005 | |
| 0.186 | 0.014 | 0.186 | Alcohol dehydrogenase inhibitor | 0.138 0.025 CID_20717005 | ||
| 0.214 | 0.041 | 0.214 | Cytidine deaminase inhibitor | |||
| 0.171 | 0.004 | 0.309 | Mannosidase inhibitor | 0.309 0.002 CID_20717005 | CID_20717005 | |
| 0.186 | 0.019 | 0.186 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.175 | 0.011 | 0.175 | Keratolytic | |||
| 0.177 | 0.013 | 0.177 | Prolactin inhibitor | |||
| 0.226 | 0.062 | 0.322 | DNA methylase inhibitor | 0.322 0.022 CID_20717005 | CID_20717005 | |
| 0.166 | 0.002 | 0.204 | Glucose-6-phosphate isomerase inhibitor | 0.204 0.002 CID_20717005 | CID_20717005 | |
| 0.168 | 0.008 | 0.202 | Interferon agonist | 0.202 0.006 CID_20717005 | CID_20717005 | |
| 0.165 | 0.006 | 0.165 | Cathepsin D inhibitor | |||
| 0.176 | 0.017 | 0.176 | Calcium antagonist | |||
| 0.183 | 0.024 | 0.183 | MAP3K9 inhibitor | |||
| 0.166 | 0.007 | 0.166 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.175 | 0.018 | 0.175 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.198 | 0.042 | 0.198 | Interleukin 6 antagonist | 0.169 0.065 CID_20717005 | ||
| 0.172 | 0.018 | 0.172 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.214 | 0.06 | 0.369 | Non-steroidal antiinflammatory agent | 0.369 0.017 CID_20717005 | CID_20717005 | |
| 0.166 | 0.013 | 0.166 | CYP2A6 inhibitor | |||
| 0.179 | 0.029 | 0.179 | Nav1.6 sodium channel blocker | |||
| 0.189 | 0.039 | 0.189 | Bone formation stimulant | 0.153 0.057 CID_20717005 | ||
| 0.161 | 0.013 | 0.161 | Anabolic | 0.114 0.045 CID_20717005 | ||
| 0.16 | 0.013 | 0.16 | MAP kinase kinase 1 inhibitor | |||
| 0.163 | 0.016 | 0.163 | DOPA decarboxylase inhibitor | |||
| 0.179 | 0.032 | 0.179 | Nav1.3 sodium channel blocker | |||
| 0.21 | 0.064 | 0.262 | DNA methyltransferase I inhibitor | 0.262 0.042 CID_20717005 | CID_20717005 | |
| 0.149 | 0.005 | 0.149 | Prostaglandin F2 alpha antagonist | |||
| 0.159 | 0.016 | 0.159 | Electron transport complex I inhibitor | |||
| 0.165 | 0.022 | 0.165 | TRPA1 agonist | |||
| 0.176 | 0.035 | 0.313 | Alkylator | 0.313 0.012 CID_20717005 | CID_20717005 | |
| 0.188 | 0.049 | 0.282 | Diuretic | 0.282 0.026 CID_20717005 | CID_20717005 | |
| 0.142 | 0.004 | 0.142 | Exportin-1 inhibitor | |||
| 0.162 | 0.026 | 0.162 | Heat shock protein 70 antagonist | 0.157 0.032 CID_20717005 | ||
| 0.143 | 0.008 | 0.143 | Glycine receptor agonist | 0.143 0.008 CID_20717005 | ||
| 0.142 | 0.008 | 0.142 | Purinergic P2X1 antagonist | 0.089 0.02 CID_20717005 | ||
| 0.177 | 0.044 | 0.177 | Nav1.2 sodium channel blocker | |||
| 0.144 | 0.011 | 0.205 | Phosphodiesterase 6D inhibitor | 0.205 0.004 CID_20717005 | CID_20717005 | |
| 0.152 | 0.02 | 0.263 | Toll-Like receptor 4 antagonist | 0.263 0.004 CID_20717005 | CID_20717005 | |
| 0.17 | 0.039 | 0.252 | DNA polymerase I inhibitor | 0.252 0.017 CID_20717005 | CID_20717005 | |
| 0.146 | 0.018 | 0.545 | Selectin antagonist | 0.545 0.002 CID_20717005 | CID_20717005 | |
| 0.138 | 0.011 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.127 0.015 CID_20717005 | ||
| 0.133 | 0.006 | 0.133 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.138 | 0.011 | 0.138 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.155 | 0.029 | 0.155 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.154 | 0.029 | 0.211 | Photosensitizer | 0.211 0.011 CID_20717005 | CID_20717005 | |
| 0.156 | 0.033 | 0.156 | Vanilloid 1 agonist | 0.146 0.042 CID_20717005 | ||
| 0.127 | 0.006 | 0.127 | GABA B receptor agonist | |||
| 0.139 | 0.018 | 0.139 | Adrenaline agonist | |||
| 0.147 | 0.026 | 0.147 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.127 | 0.006 | 0.145 | Interferon inducer | 0.145 0.005 CID_20717005 | CID_20717005 | |
| 0.137 | 0.017 | 0.137 | Somatostatin 1 agonist | |||
| 0.136 | 0.016 | 0.136 | Ornithine decarboxylase inhibitor | 0.09 0.055 CID_20717005 | ||
| 0.148 | 0.029 | 0.148 | Carbonic anhydrase III inhibitor | 0.115 0.048 CID_20717005 | ||
| 0.123 | 0.005 | 0.123 | Glutamate (mGluR6) antagonist | 0.073 0.034 CID_20717005 | ||
| 0.129 | 0.012 | 0.133 | Toll-Like receptor 2 agonist | 0.133 0.012 CID_20717005 | CID_20717005 | |
| 0.13 | 0.014 | 0.166 | Glycine receptor antagonist | 0.166 0.005 CID_20717005 | CID_20717005 | |
| 0.12 | 0.004 | 0.12 | Calcium channel P-type blocker | |||
| 0.121 | 0.006 | 0.121 | Vanilloid 4 agonist | |||
| 0.173 | 0.058 | 0.173 | Neurotensin receptor agonist | |||
| 0.128 | 0.013 | 0.151 | GABA aminotransferase inhibitor | 0.151 0.008 CID_20717005 | CID_20717005 | |
| 0.119 | 0.005 | 0.119 | Sphingosine kinase inhibitor | |||
| 0.196 | 0.083 | 0.196 | Pyruvate kinase inhibitor | |||
| 0.125 | 0.013 | 0.125 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.165 | 0.053 | 0.532 | Hemostatic | 0.532 0.004 CID_20717005 | CID_20717005 | |
| 0.129 | 0.018 | 0.129 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.13 | 0.019 | 0.13 | Neuropeptide agonist | |||
| 0.137 | 0.026 | 0.137 | Androgen antagonist | |||
| 0.12 | 0.01 | 0.12 | Beta 3 adrenoreceptor antagonist | |||
| 0.142 | 0.033 | 0.518 | AMP-activated protein kinase stimulant | 0.518 0.003 CID_20717005 | CID_20717005 | |
| 0.113 | 0.005 | 0.113 | Sphingosine kinase 2 inhibitor | |||
| 0.116 | 0.009 | 0.116 | Cathepsin E inhibitor | |||
| 0.112 | 0.005 | 0.112 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.153 | 0.047 | 0.153 | Pregnane X receptor agonist | |||
| 0.212 | 0.106 | 0.25 | DNA damaging | 0.25 0.08 CID_20717005 | CID_20717005 | |
| 0.117 | 0.011 | 0.117 | Estrogen-related receptor beta agonist | |||
| 0.127 | 0.022 | 0.247 | Transcription factor NF kappa B stimulant | 0.247 0.006 CID_20717005 | CID_20717005 | |
| 0.116 | 0.011 | 0.116 | Beta adrenoreceptor antagonist | |||
| 0.153 | 0.05 | 0.153 | MAP kinase kinase inhibitor | |||
| 0.198 | 0.096 | 0.86 | Angiogenesis stimulant | 0.86 0.003 CID_20717005 | CID_20717005 | |
| 0.133 | 0.031 | 0.154 | Acetylcholine release stimulant | 0.154 0.014 CID_20717005 | CID_20717005 | |
| 0.142 | 0.04 | 0.142 | Falcipain 3 inhibitor | |||
| 0.137 | 0.036 | 0.137 | Carbonic anhydrase XV inhibitor | |||
| 0.122 | 0.022 | 0.122 | Glutathione S-transferase inhibitor | |||
| 0.177 | 0.078 | 0.629 | Nitric oxide antagonist | 0.629 0.008 CID_20717005 | CID_20717005 | |
| 0.147 | 0.048 | 0.505 | Monophenol monooxygenase inhibitor | 0.505 0.008 CID_20717005 | CID_20717005 | |
| 0.115 | 0.016 | 0.115 | D-Ala-D-Ala ligase inhibitor | |||
| 0.111 | 0.013 | 0.111 | Secretase beta inhibitor | |||
| 0.134 | 0.037 | 0.384 | Mediator release inhibitor | 0.384 0.005 CID_20717005 | CID_20717005 | |
| 0.116 | 0.019 | 0.131 | Na+ K+ transporting ATPase inhibitor | 0.131 0.011 CID_20717005 | CID_20717005 | |
| 0.161 | 0.064 | 0.174 | Phospholipase A2 inhibitor | 0.174 0.057 CID_20717005 | CID_20717005 | |
| 0.101 | 0.004 | 0.101 | Adenylate cyclase 1 inhibitor | |||
| 0.105 | 0.008 | 0.105 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.106 | 0.011 | 0.106 | Phospholipase D inhibitor | |||
| 0.099 | 0.005 | 0.099 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.103 | 0.009 | 0.103 | Glutamate (mGluR7) antagonist | |||
| 0.099 | 0.007 | 0.099 | Phosphoglycerate kinase inhibitor | 0.042 0.018 CID_20717005 | ||
| 0.097 | 0.005 | 0.097 | HIV-1 protease inhibitor | |||
| 0.096 | 0.004 | 0.096 | Immunoglobulin Fc receptor antagonist | |||
| 0.098 | 0.007 | 0.098 | MDM2 inhibitor | |||
| 0.1 | 0.01 | 0.1 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.015 | 0.105 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.018 CID_20717005 | ||
| 0.096 | 0.006 | 0.096 | Adenosine deaminase inhibitor | 0.083 0.009 CID_20717005 | ||
| 0.194 | 0.105 | 0.452 | Platelet antagonist | 0.452 0.019 CID_20717005 | CID_20717005 | |
| 0.119 | 0.03 | 0.119 | Carbonic anhydrase XIII inhibitor | 0.106 0.035 CID_20717005 | ||
| 0.106 | 0.019 | 0.106 | Glucagon-like peptide 1 agonist | |||
| 0.169 | 0.081 | 0.169 | Lipocortins synthesis antagonist | 0.151 0.103 CID_20717005 | ||
| 0.115 | 0.028 | 0.115 | Cathepsin G inhibitor | |||
| 0.11 | 0.024 | 0.11 | mTOR complex 2 inhibitor | |||
| 0.099 | 0.013 | 0.099 | MAP kinase kinase 7 inhibitor | |||
| 0.089 | 0.005 | 0.089 | Sphingosine kinase 1 inhibitor | |||
| 0.089 | 0.004 | 0.089 | Neuraminidase (Influenza A) inhibitor | 0.084 0.005 CID_20717005 | ||
| 0.094 | 0.01 | 0.094 | Glucosylceramidase inhibitor | 0.077 0.017 CID_20717005 | ||
| 0.137 | 0.054 | 0.137 | Proteasome inhibitor | |||
| 0.112 | 0.029 | 0.112 | Bile acid receptor antagonist | |||
| 0.126 | 0.044 | 0.27 | Xanthine oxidase inhibitor | 0.27 0.01 CID_20717005 | CID_20717005 | |
| 0.098 | 0.017 | 0.098 | NMDA receptor glycine site agonist | |||
| 0.196 | 0.117 | 0.741 | Antioxidant | 0.741 0.005 CID_20717005 | CID_20717005 | |
| 0.095 | 0.017 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.097 | 0.02 | 0.097 | NMDA receptor agonist | |||
| 0.086 | 0.01 | 0.086 | Aldosterone antagonist | |||
| 0.15 | 0.074 | 0.15 | Acetylcholine M1 receptor antagonist | |||
| 0.081 | 0.004 | 0.081 | Calcium-sensing receptor antagonist | |||
| 0.105 | 0.031 | 0.105 | Hematopoietic | |||
| 0.083 | 0.008 | 0.083 | Sphingosine 1-phosphate receptor agonist | |||
| 0.078 | 0.004 | 0.078 | HMG CoA reductase inhibitor | 0.038 0.017 CID_20717005 | ||
| 0.087 | 0.013 | 0.087 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.107 | 0.034 | 0.107 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.077 | 0.005 | 0.077 | Geranyltranstransferase inhibitor | |||
| 0.079 | 0.007 | 0.079 | Prostaglandin agonist | |||
| 0.125 | 0.055 | 0.125 | Interleukin 8 antagonist | |||
| 0.081 | 0.011 | 0.081 | Beta 2 adrenoreceptor antagonist | |||
| 0.076 | 0.007 | 0.076 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.077 | 0.008 | 0.077 | Pregnane X receptor antagonist | |||
| 0.073 | 0.004 | 0.085 | Uridine phosphorylase inhibitor | 0.085 0.003 CID_20717005 | CID_20717005 | |
| 0.15 | 0.082 | 0.385 | Thrombolytic | 0.385 0.013 CID_20717005 | CID_20717005 | |
| 0.072 | 0.004 | 0.072 | Kainate receptor agonist | 0.041 0.03 CID_20717005 | ||
| 0.072 | 0.004 | 0.072 | Guanylate cyclase inhibitor | 0.07 0.005 CID_20717005 | ||
| 0.078 | 0.012 | 0.078 | Dihydroorotate oxidase inhibitor | |||
| 0.075 | 0.009 | 0.075 | Glutamate (mGluR1a) antagonist | |||
| 0.103 | 0.037 | 0.103 | Bromodomain-containing protein 2 inhibitor | |||
| 0.072 | 0.007 | 0.072 | Membrane dipeptidase inhibitor | |||
| 0.069 | 0.004 | 0.069 | Plasmepsin I inhibitor | |||
| 0.069 | 0.005 | 0.069 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.068 | 0.003 | 0.068 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.114 | 0.049 | 0.114 | Gastric antisecretory | |||
| 0.126 | 0.061 | 0.209 | DNA repair enzyme inhibitor | 0.209 0.008 CID_20717005 | CID_20717005 | |
| 0.086 | 0.022 | 0.086 | Potassium channel (Tandem pore domain) blocker | |||
| 0.104 | 0.041 | 0.104 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.085 | 0.021 | 0.085 | Androgen agonist | |||
| 0.087 | 0.024 | 0.087 | Ribonucleotide reductase inhibitor | |||
| 0.143 | 0.079 | 0.143 | MAP kinase 3 inhibitor | |||
| 0.07 | 0.007 | 0.07 | GABA uptake inhibitor | |||
| 0.11 | 0.047 | 0.11 | Potassium channel (Ca-activated) activator | |||
| 0.13 | 0.067 | 0.13 | Antibacterial (Helicobacter pylori) | |||
| 0.085 | 0.023 | 0.085 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.153 | 0.09 | 0.153 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.067 | 0.005 | 0.067 | Glutamate (mGluR8) agonist | |||
| 0.072 | 0.01 | 0.072 | Renin inhibitor | |||
| 0.106 | 0.044 | 0.406 | Antineoplastic antibiotic | 0.406 0.005 CID_20717005 | CID_20717005 | |
| 0.108 | 0.046 | 0.108 | Glutamate (mGluR7) agonist | |||
| 0.121 | 0.059 | 0.121 | Caspase 3 inhibitor | |||
| 0.09 | 0.028 | 0.095 | Phosphodiesterase VI inhibitor | 0.095 0.024 CID_20717005 | CID_20717005 | |
| 0.069 | 0.007 | 0.103 | Cytokine production stimulant | 0.103 0.004 CID_20717005 | CID_20717005 | |
| 0.064 | 0.003 | 0.064 | Prostaglandin F2 alpha agonist | 0.025 0.013 CID_20717005 | ||
| 0.093 | 0.032 | 0.093 | CC chemokine 5 receptor agonist | |||
| 0.206 | 0.145 | 0.233 | Hypoxia-inducible factor 1 alpha inhibitor | 0.233 0.116 CID_20717005 | CID_20717005 | |
| 0.068 | 0.009 | 0.068 | Dopamine D5 agonist | |||
| 0.073 | 0.014 | 0.073 | Ryanodine receptor antagonist | |||
| 0.084 | 0.024 | 0.084 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.065 | 0.006 | 0.065 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.069 | 0.01 | 0.069 | Retinoid X receptor agonist | |||
| 0.063 | 0.004 | 0.063 | Cholesterol ester transfer protein antagonist | |||
| 0.063 | 0.004 | 0.063 | Prostaglandin EP4 agonist | |||
| 0.077 | 0.019 | 0.077 | Botulinum neurotoxin type A inhibitor | |||
| 0.079 | 0.021 | 0.079 | Heat shock protein 90 beta antagonist | |||
| 0.071 | 0.013 | 0.071 | Squalene epoxidase inhibitor | 0.058 0.023 CID_20717005 | ||
| 0.089 | 0.032 | 0.089 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.075 | 0.018 | 0.234 | Phosphorylase inhibitor | 0.234 0.004 CID_20717005 | CID_20717005 | |
| 0.139 | 0.083 | 0.139 | Neuropeptide Y1 antagonist | |||
| 0.079 | 0.023 | 0.079 | Carbonic anhydrase VB inhibitor | |||
| 0.06 | 0.005 | 0.06 | ATP citrate lysase inhibitor | |||
| 0.084 | 0.029 | 0.084 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.095 | 0.039 | 0.095 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.076 | 0.021 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.096 | 0.042 | 0.096 | Carbonic anhydrase VI inhibitor | 0.072 0.069 CID_20717005 | ||
| 0.066 | 0.012 | 0.066 | Thymidine kinase inhibitor | 0.04 0.03 CID_20717005 | ||
| 0.08 | 0.026 | 0.08 | Carbonic anhydrase stimulant | |||
| 0.138 | 0.083 | 0.138 | Thiol protease inhibitor | |||
| 0.071 | 0.017 | 0.071 | Beta 2 adrenoreceptor agonist | |||
| 0.064 | 0.01 | 0.064 | GABA B receptor antagonist | |||
| 0.061 | 0.008 | 0.061 | Glutamate (mGluR3) antagonist | |||
| 0.063 | 0.009 | 0.063 | Farnesoid X receptor agonist | |||
| 0.06 | 0.007 | 0.06 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.042 0.011 CID_20717005 | ||
| 0.12 | 0.068 | 0.13 | Beta amyloid protein antagonist | 0.13 0.057 CID_20717005 | CID_20717005 | |
| 0.057 | 0.006 | 0.057 | Prostaglandin D2 agonist | |||
| 0.06 | 0.008 | 0.06 | Purinergic P2X3 antagonist | |||
| 0.07 | 0.018 | 0.07 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.053 | 0.002 | 0.053 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.06 | 0.01 | 0.09 | Arginase inhibitor | 0.09 0.005 CID_20717005 | CID_20717005 | |
| 0.062 | 0.013 | 0.062 | Dopamine beta hydroxylase inhibitor | |||
| 0.132 | 0.082 | 0.372 | Lipid peroxidase inhibitor | 0.372 0.011 CID_20717005 | CID_20717005 | |
| 0.054 | 0.005 | 0.054 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.063 | 0.014 | 0.063 | Growth hormone release inhibitor | |||
| 0.147 | 0.098 | 0.147 | Antipruritic | |||
| 0.054 | 0.006 | 0.138 | Sodium/glucose cotransporter 2 inhibitor | 0.138 0.002 CID_20717005 | CID_20717005 | |
| 0.066 | 0.018 | 0.066 | Leukotriene C antagonist | |||
| 0.107 | 0.059 | 0.107 | Urease inhibitor | |||
| 0.081 | 0.034 | 0.081 | Acetylcholine M5 receptor agonist | |||
| 0.065 | 0.019 | 0.065 | Topoisomerase II beta inhibitor | 0.047 0.039 CID_20717005 | ||
| 0.052 | 0.005 | 0.052 | Prostaglandin EP2 agonist | 0.022 0.016 CID_20717005 | ||
| 0.06 | 0.015 | 0.06 | Calcitonin receptor agonist | |||
| 0.078 | 0.033 | 0.078 | Leukotriene antagonist | 0.067 0.042 CID_20717005 | ||
| 0.066 | 0.021 | 0.066 | Bombesin 2 receptor antagonist | |||
| 0.051 | 0.006 | 0.051 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.055 | 0.011 | 0.055 | Beta adrenoreceptor agonist | |||
| 0.095 | 0.051 | 0.095 | Histamine N-methyltransferase inhibitor | |||
| 0.059 | 0.016 | 0.063 | Microtubule stabilization | 0.063 0.011 CID_20717005 | CID_20717005 | |
| 0.046 | 0.003 | 0.046 | Carbonic anhydrase VIII inhibitor | |||
| 0.046 | 0.003 | 0.046 | Carbonic anhydrase X inhibitor | |||
| 0.065 | 0.022 | 0.065 | Epithelial sodium channel blocker | |||
| 0.047 | 0.004 | 0.047 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.053 | 0.01 | 0.053 | Heme oxygenase inhibitor | |||
| 0.055 | 0.013 | 0.055 | Retinoid X alpha receptor agonist | |||
| 0.045 | 0.003 | 0.045 | Neuraminidase (Influenza B) inhibitor | 0.033 0.004 CID_20717005 | ||
| 0.055 | 0.013 | 0.055 | Alpha 1d adrenoreceptor agonist | |||
| 0.05 | 0.008 | 0.05 | Vanilloid 3 antagonist | |||
| 0.046 | 0.005 | 0.046 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_20717005 | ||
| 0.099 | 0.059 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.046 | 0.005 | 0.171 | Sodium/glucose cotransporter inhibitor | 0.171 0.002 CID_20717005 | CID_20717005 | |
| 0.136 | 0.096 | 0.136 | MAP kinase kinase 4 inhibitor | |||
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | |||
| 0.045 | 0.006 | 0.045 | Prostaglandin E2 agonist | |||
| 0.177 | 0.138 | 0.177 | Calpain inhibitor | |||
| 0.051 | 0.013 | 0.051 | p53 inhibitor | |||
| 0.042 | 0.005 | 0.042 | Prostacyclin agonist | |||
| 0.062 | 0.025 | 0.062 | Antimetabolite | 0.055 0.028 CID_20717005 | ||
| 0.068 | 0.032 | 0.068 | Glutamate (mGluR1) antagonist | |||
| 0.078 | 0.042 | 0.078 | Calcium channel L-type blocker | |||
| 0.054 | 0.018 | 0.054 | AICAR transformylase inhibitor | |||
| 0.061 | 0.026 | 0.061 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.044 | 0.008 | 0.044 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.152 | 0.117 | 0.152 | I kappa B kinase epsilon inhibitor | |||
| 0.043 | 0.008 | 0.043 | Glutamate (mGluR3) agonist | |||
| 0.04 | 0.005 | 0.04 | Aminopeptidase P inhibitor | |||
| 0.044 | 0.01 | 0.044 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.038 | 0.004 | 0.053 | Vanilloid 2 agonist | 0.053 0.003 CID_20717005 | CID_20717005 | |
| 0.078 | 0.044 | 0.078 | Epoxide hydrolase inhibitor | |||
| 0.048 | 0.015 | 0.048 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.067 | 0.033 | 0.067 | Xanthine dehydrogenase inhibitor | 0.063 0.036 CID_20717005 | ||
| 0.039 | 0.006 | 0.039 | Glutamate (mGluR1) agonist | |||
| 0.058 | 0.025 | 0.233 | Heparanase inhibitor | 0.233 0.002 CID_20717005 | CID_20717005 | |
| 0.074 | 0.042 | 0.074 | Carbonic anhydrase VA inhibitor | |||
| 0.06 | 0.028 | 0.066 | Leukotriene B4 antagonist | 0.066 0.022 CID_20717005 | CID_20717005 | |
| 0.047 | 0.015 | 0.112 | Antibiotic Aminoglycoside-like | 0.112 0.002 CID_20717005 | CID_20717005 | |
| 0.056 | 0.025 | 0.056 | Potassium channel (Inward rectifier) activator | |||
| 0.066 | 0.034 | 0.066 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.033 | 0.001 | 0.033 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.043 | 0.012 | 0.043 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.041 | 0.01 | 0.041 | Lysine carboxypeptidase inhibitor | |||
| 0.034 | 0.004 | 0.034 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_20717005 | ||
| 0.103 | 0.073 | 0.103 | 5 Hydroxytryptamine 3A agonist | |||
| 0.054 | 0.024 | 0.054 | Cholesterol esterase inhibitor | |||
| 0.053 | 0.024 | 0.053 | Potassium channel (ATP-sensitive) activator | |||
| 0.037 | 0.007 | 0.037 | Estrogen-related receptor gamma antagonist | |||
| 0.048 | 0.019 | 0.048 | Plasmepsin II inhibitor | |||
| 0.036 | 0.007 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.102 | 0.073 | 0.102 | Protein kinase C gamma inhibitor | |||
| 0.072 | 0.043 | 0.072 | Sirtuin 1 inhibitor | |||
| 0.048 | 0.019 | 0.048 | G protein-coupled receptor agonist | |||
| 0.045 | 0.017 | 0.045 | Retinoid X receptor antagonist | |||
| 0.035 | 0.007 | 0.035 | Nicotinic acid receptor 2 antagonist | |||
| 0.054 | 0.027 | 0.054 | HCV NS3/NS4A protease inhibitor | |||
| 0.03 | 0.003 | 0.039 | Telomerase stimulant | 0.039 0.002 CID_20717005 | CID_20717005 | |
| 0.059 | 0.032 | 0.23 | Protein 50S ribosomal subunit inhibitor | 0.23 0.004 CID_20717005 | CID_20717005 | |
| 0.19 | 0.163 | 0.19 | 12-Lipoxygenase inhibitor | |||
| 0.109 | 0.082 | 0.109 | Transcription factor STAT6 inhibitor | |||
| 0.054 | 0.028 | 0.054 | CD45 antagonist | |||
| 0.029 | 0.003 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 CID_20717005 | ||
| 0.029 | 0.003 | 0.029 | Thromboxane A2 agonist | |||
| 0.05 | 0.024 | 0.05 | Oxytocin agonist | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.054 | 0.029 | 0.126 | Carbonic anhydrase XIV inhibitor | 0.126 0.006 CID_20717005 | CID_20717005 | |
| 0.069 | 0.044 | 0.069 | Carbonic anhydrase V inhibitor | |||
| 0.057 | 0.032 | 0.057 | Thromboxane synthase inhibitor | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.043 | 0.018 | 0.043 | Leukotriene C4 antagonist | |||
| 0.029 | 0.004 | 0.052 | Antibiotic Anthracycline-like | 0.052 0.002 CID_20717005 | CID_20717005 | |
| 0.056 | 0.031 | 0.056 | Thromboxane A2 antagonist | |||
| 0.036 | 0.012 | 0.036 | Prostaglandin EP4 antagonist | |||
| 0.043 | 0.019 | 0.043 | Nicotinic acid receptor agonist | |||
| 0.058 | 0.034 | 0.058 | Thromboxane antagonist | |||
| 0.083 | 0.06 | 0.083 | Myeloperoxidase inhibitor | |||
| 0.206 | 0.182 | 0.206 | Calpain 2 inhibitor | |||
| 0.057 | 0.034 | 0.153 | Adenine nucleotide translocase inhibitor | 0.153 0.003 CID_20717005 | CID_20717005 | |
| 0.046 | 0.023 | 0.046 | Angiotensin AT1 receptor antagonist | |||
| 0.066 | 0.043 | 0.066 | Aryl hydrocarbon receptor antagonist | |||
| 0.04 | 0.017 | 0.04 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.04 | 0.018 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.018 CID_20717005 | ||
| 0.027 | 0.005 | 0.04 | Ileal bile acid transport inhibitor | 0.04 0.004 CID_20717005 | CID_20717005 | |
| 0.073 | 0.051 | 0.073 | Metalloproteinase-9 inhibitor | |||
| 0.03 | 0.009 | 0.03 | Glutamate (mGluR1a) agonist | |||
| 0.064 | 0.043 | 0.064 | Transcription factor RelA inhibitor | |||
| 0.028 | 0.007 | 0.028 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.069 | 0.049 | 0.069 | Protein kinase C beta inhibitor | |||
| 0.037 | 0.017 | 0.037 | Carboxypeptidase B inhibitor | |||
| 0.03 | 0.012 | 0.03 | Thymidine phosphorylase inhibitor | |||
| 0.087 | 0.068 | 0.087 | Polo-like kinase-1 inhibitor | |||
| 0.047 | 0.028 | 0.047 | Dihydroorotase inhibitor | |||
| 0.028 | 0.009 | 0.028 | Beta 1 adrenoreceptor agonist | |||
| 0.037 | 0.019 | 0.037 | Free fatty acid receptor 1 antagonist | |||
| 0.113 | 0.095 | 0.176 | Interleukin 4 antagonist | 0.176 0.031 CID_20717005 | CID_20717005 | |
| 0.041 | 0.023 | 0.041 | Vascular adhesion protein 1 inhibitor | |||
| 0.047 | 0.029 | 0.047 | Purinergic P2Y antagonist | 0.04 0.036 CID_20717005 | ||
| 0.023 | 0.005 | 0.023 | Vitamin D receptor agonist | 0.019 0.007 CID_20717005 | ||
| 0.025 | 0.007 | 0.025 | Retinoid X beta receptor antagonist | |||
| 0.021 | 0.004 | 0.021 | Thromboxane agonist | |||
| 0.058 | 0.041 | 0.058 | Cyclin H inhibitor | |||
| 0.035 | 0.019 | 0.035 | Protein kinase (CK2) beta inhibitor | |||
| 0.074 | 0.059 | 0.074 | Macrophage migration inhibitory factor inhibitor | |||
| 0.043 | 0.028 | 0.043 | Nerve growth factor antagonist | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR4) antagonist | |||
| 0.042 | 0.028 | 0.042 | Liver X receptor alpha agonist | |||
| 0.024 | 0.011 | 0.024 | Vitamin D receptor antagonist | 0.022 0.015 CID_20717005 | ||
| 0.034 | 0.021 | 0.074 | Squalene synthetase inhibitor | 0.074 0.009 CID_20717005 | CID_20717005 | |
| 0.03 | 0.016 | 0.03 | LFA antagonist | |||
| 0.018 | 0.005 | 0.018 | Glutamate (mGluR6) agonist | |||
| 0.044 | 0.032 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.062 | 0.049 | 0.062 | Neutrophil collagenase inhibitor | |||
| 0.046 | 0.033 | 0.046 | Carbonic anhydrase VII inhibitor | |||
| 0.025 | 0.012 | 0.025 | ICAM 1 antagonist | |||
| 0.022 | 0.009 | 0.022 | Aminopeptidase A inhibitor | |||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | |||
| 0.019 | 0.007 | 0.019 | Purinergic P2Y1 agonist | |||
| 0.059 | 0.047 | 0.059 | NMDA 2C receptor antagonist | |||
| 0.022 | 0.01 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.034 | 0.024 | 0.034 | Angiotensin II receptor antagonist | |||
| 0.089 | 0.079 | 0.089 | Nitric-oxide synthase inhibitor | |||
| 0.038 | 0.028 | 0.038 | MAP3K5 inhibitor | |||
| 0.045 | 0.035 | 0.045 | Thymidylate synthase inhibitor | |||
| 0.034 | 0.025 | 0.034 | Somatostatin 5 agonist | |||
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.034 | 0.024 | 0.034 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.077 | 0.069 | 0.077 | Caspase 7 inhibitor | |||
| 0.029 | 0.021 | 0.029 | Glucagon receptor antagonist | |||
| 0.034 | 0.025 | 0.034 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.032 | 0.024 | 0.032 | Liver X receptor beta agonist | |||
| 0.038 | 0.03 | 0.038 | AMPA 4 receptor antagonist | |||
| 0.072 | 0.064 | 0.072 | Estrogen receptor alpha antagonist | |||
| 0.02 | 0.013 | 0.02 | Follicle-stimulating hormone antagonist | |||
| 0.084 | 0.077 | 0.084 | Protein kinase C zeta inhibitor | |||
| 0.025 | 0.019 | 0.025 | Thyroid hormone agonist | |||
| 0.03 | 0.023 | 0.03 | Somatostatin 5 antagonist | |||
| 0.029 | 0.022 | 0.029 | Prostaglandin EP3 antagonist | |||
| 0.04 | 0.034 | 0.04 | Macrophage elastase inhibitor | |||
| 0.091 | 0.085 | 0.254 | Beta glucuronidase inhibitor | 0.254 0.008 CID_20717005 | CID_20717005 | |
| 0.026 | 0.02 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.017 | 0.011 | 0.017 | G-protein-coupled receptor 120 agonist | |||
| 0.076 | 0.07 | 0.076 | Inducible nitric-oxide synthase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Hexokinase stimulant | |||
| 0.019 | 0.013 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.027 | 0.022 | 0.027 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.037 | 0.031 | 0.037 | Dihydropteroate synthase inhibitor | |||
| 0.051 | 0.045 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.078 | 0.073 | 0.078 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.055 | 0.05 | 0.055 | Acetylcholine M5 receptor antagonist | |||
| 0.098 | 0.093 | 0.098 | Acetylcholine muscarinic antagonist | |||
| 0.093 | 0.088 | 0.101 | Chelator | 0.101 0.076 CID_20717005 | CID_20717005 | |
| 0.052 | 0.048 | 0.052 | Fatty acid synthase inhibitor | |||
| 0.049 | 0.045 | 0.049 | Vanilloid 2 antagonist | |||
| 0.028 | 0.024 | 0.028 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.027 | 0.023 | 0.027 | Vasopressin 1A agonist | |||
| 0.054 | 0.05 | 0.054 | Collagenase 3 inhibitor | |||
| 0.016 | 0.012 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.017 | 0.014 | 0.017 | Cyclin T1 inhibitor | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.011 | 0.008 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.035 | 0.032 | 0.035 | Urate transporter 1 inhibitor | |||
| 0.021 | 0.018 | 0.021 | Growth hormone releasing factor antagonist | |||
| 0.069 | 0.067 | 0.069 | Metalloproteinase-2 inhibitor | |||
| 0.019 | 0.016 | 0.019 | Caspase 8 inhibitor | |||
| 0.019 | 0.016 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.046 | 0.044 | 0.046 | Prostaglandin antagonist | |||
| 0.021 | 0.019 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.045 | 0.043 | 0.045 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.04 | 0.038 | 0.04 | Endothelin-converting enzyme inhibitor | |||
| 0.083 | 0.081 | 0.083 | ABCA1 expression enhancer | |||
| 0.018 | 0.015 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.016 | 0.014 | 0.016 | CC chemokine 9 receptor antagonist | |||
| 0.02 | 0.018 | 0.02 | Follicle-stimulating hormone agonist | |||
| 0.048 | 0.046 | 0.048 | Human rhinovirus A protease inhibitor | |||
| 0.029 | 0.027 | 0.029 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.01 | 0.009 | 0.01 | Beta 3 adrenoreceptor agonist | |||
| 0.032 | 0.031 | 0.032 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.057 | 0.055 | 0.086 | Nitric oxide donor | 0.086 0.018 CID_20717005 | CID_20717005 | |
| 0.033 | 0.032 | 0.033 | Diamine oxidase inhibitor | |||
| 0.013 | 0.012 | 0.013 | Adenosine A2a receptor agonist | |||
| 0.024 | 0.023 | 0.024 | Acid ceramidase inhibitor | |||
| 0.054 | 0.053 | 0.054 | Cyclin D1 inhibitor | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.024 | 0.023 | 0.024 | Complement factor 1s inhibitor | |||
| 0.009 | 0.009 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.005 CID_20717005 | CID_20717005 | |
| 0.104 | 0.109 | 0.189 | Alkaline phosphatase inhibitor | 0.189 0.038 CID_20717005 | CID_20717005 | |
| 0.023 | 0.029 | 0.058 | Toll-Like receptor 4 agonist | 0.058 0.003 CID_20717005 | CID_20717005 | |
| 0.052 | 0.06 | 0.077 | Lipocortins synthesis agonist | 0.077 0.015 CID_20717005 | CID_20717005 | |
| 0.145 | 0.155 | 0.323 | Antiamyloidogenic | 0.323 0.045 CID_20717005 | CID_20717005 | |
| 0.011 | 0.023 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 CID_20717005 | CID_20717005 | |
| 0.016 | 0.029 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.016 CID_20717005 | CID_20717005 | |
| 0.041 | 0.056 | 0.122 | Factor IXa inhibitor | 0.122 0.005 CID_20717005 | CID_20717005 | |
| 0.017 | 0.032 | 0.088 | Protein 30S ribosomal subunit inhibitor | 0.088 0.004 CID_20717005 | CID_20717005 | |
| 0.075 | 0.097 | 0.233 | Uric acid excretion stimulant | 0.233 0.009 CID_20717005 | CID_20717005 | |
| 0.022 | 0.044 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_20717005 | CID_20717005 | |
| 0.173 | 0.197 | 0.681 | Immunomodulator | 0.681 0.006 CID_20717005 | CID_20717005 | |
| 0.004 | 0.03 | 0.025 | Antibiotic Macrolide-like | 0.025 0.005 CID_20717005 | CID_20717005 | |
| 0.012 | 0.042 | 0.028 | Corticosteroid-like | 0.028 0.008 CID_20717005 | CID_20717005 | |
| 0.004 | 0.045 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_20717005 | CID_20717005 | |
| 0.004 | 0.045 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_20717005 | CID_20717005 | |
| 0.131 | 0.175 | 0.684 | Free radical scavenger | 0.684 0.005 CID_20717005 | CID_20717005 | |
| 0.06 | 0.136 | 0.17 | Protein-tyrosine phosphatase 1B inhibitor | 0.17 0.038 CID_20717005 | CID_20717005 | |
| 0.015 | 0.092 | 0.05 | Carbonic anhydrase XII inhibitor | 0.05 0.038 CID_20717005 | CID_20717005 | |
| 0.098 | 0.179 | 0.503 | Platelet adhesion inhibitor | 0.503 0.005 CID_20717005 | CID_20717005 | |
| 0.092 | 0.186 | 0.376 | NOS3 expression enhancer | 0.376 0.009 CID_20717005 | CID_20717005 | |
| 0.121 | 0.222 | 0.171 | Growth factor agonist | 0.171 0.1 CID_20717005 | CID_20717005 | |
| 0.077 | 0.196 | 0.166 | Protein-tyrosine phosphatase inhibitor | 0.166 0.065 CID_20717005 | CID_20717005 | |
| 0.146 | 0.268 | 0.591 | Alpha-glucosidase inhibitor | 0.591 0.056 CID_20717005 | CID_20717005 | |
| 0.147 | 0.284 | 0.338 | Caspase 3 stimulant | 0.338 0.063 CID_20717005 | CID_20717005 | |
| 0.031 | 0.18 | 0.209 | Topoisomerase II alpha inhibitor | 0.209 0.014 CID_20717005 | CID_20717005 | |
| 0.03 | 0.185 | 0.051 | Factor III inhibitor | 0.051 0.031 CID_20717005 | CID_20717005 | |
| 0.014 | 0.184 | 0.094 | Aldose reductase inhibitor | 0.094 0.019 CID_20717005 | CID_20717005 | |
| 0.061 | 0.237 | 0.408 | Cell adhesion inhibitor | 0.408 0.005 CID_20717005 | CID_20717005 | |
| 0.008 | 0.193 | 0.025 | Motilin receptor agonist | 0.025 0.013 CID_20717005 | CID_20717005 | |
| 0.041 | 0.238 | 0.253 | Cell adhesion molecule inhibitor | 0.253 0.006 CID_20717005 | CID_20717005 | |
| 0.031 | 0.28 | 0.335 | Topoisomerase II inhibitor | 0.335 0.014 CID_20717005 | CID_20717005 | |
| 0.07 | 0.323 | 0.624 | Tumour necrosis factor alpha release inhibitor | 0.624 0.006 CID_20717005 | CID_20717005 | |
| 0.025 | 0.293 | 0.081 | Histone deacetylase SIRT1 stimulant | 0.081 0.043 CID_20717005 | CID_20717005 | |
| 0.025 | 0.293 | 0.081 | Histone deacetylase stimulant | 0.081 0.043 CID_20717005 | CID_20717005 | |
| 0.023 | 0.31 | 0.309 | Topoisomerase I inhibitor | 0.309 0.01 CID_20717005 | CID_20717005 | |
| 0.02 | 0.321 | 0.062 | Transcription factor AP-1 inhibitor | 0.062 0.042 CID_20717005 | CID_20717005 | |
| 0.088 | 0.431 | 0.163 | CC chemokine 6 receptor antagonist | 0.163 0.011 CID_20717005 | CID_20717005 | |
| 0.016 | 0.387 | 0.1 | Glucose-6-phosphate translocase inhibitor | 0.1 0.006 CID_20717005 | CID_20717005 | |
| 0.01 | 0.43 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.026 CID_20717005 | CID_20717005 | |
| 0.028 | 0.516 | 0.187 | Amyloid beta aggregation inhibitor | 0.187 0.085 CID_20717005 | CID_20717005 | |
| 0.07 | 0.563 | 0.73 | Apoptosis agonist | 0.73 0.026 CID_20717005 | CID_20717005 | |
| 0.021 | 0.527 | 0.359 | Anticoagulant | 0.359 0.02 CID_20717005 | CID_20717005 | |
| 0.042 | 0.569 | 0.332 | Antiobesity | 0.332 0.096 CID_20717005 | CID_20717005 | |
| 0.057 | 0.657 | 0.871 | Antiinflammatory | 0.871 0.007 CID_20717005 | CID_20717005 | |
| 0.014 | 0.751 | 0.088 | Thioredoxin inhibitor | 0.088 0.065 CID_20717005 | CID_20717005 | |
| 0.003 | 0.745 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_20717005 | CID_20717005 | |
| 0.008 | 0.781 | 0.099 | DNA intercalator | 0.099 0.074 CID_20717005 | CID_20717005 | |
| 0.011 | 0.833 | 0.424 | Angiogenesis inhibitor | 0.424 0.047 CID_20717005 | CID_20717005 | |
| 0.008 | 0.854 | 0.133 | Multidrug resistance-associated protein 1 inhibitor | 0.133 0.036 CID_20717005 | CID_20717005 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |